SNOA
NASDAQ · Pharmaceuticals
Sonoma Pharmaceuticals Inc
$2.36
+0.02 (+0.85%)
Open$2.36
Previous Close$2.34
Day High$2.39
Day Low$2.34
52W High$6.92
52W Low$1.75
Volume—
Avg Volume14.8K
Market Cap4.21M
P/E Ratio—
EPS$-2.04
SectorPharmaceuticals
Analyst Ratings
Strong Buy
7 analysts
Price Target
+447.9% upside
Current
$2.36
$2.36
Target
$12.93
$12.93
$7.21
$12.93 avg
$14.12
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 20.17M | 19.36M | 1.82M |
| Net Income | -4,881,231 | -4,216,034 | 463.1K |
| Profit Margin | -24.2% | -23.0% | 25.4% |
| EBITDA | -4,252,875 | -3,877,381 | 609.2K |
| Free Cash Flow | — | — | 381.4K |
| Rev Growth | +4.2% | +4.2% | -7.1% |
| Debt/Equity | 0.05 | 0.05 | 0.30 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $916.31 | +1.47% | 46.4 | 957.52B |
| JNJ | Johnson & Johnson | $239.93 | +1.98% | 22.2 | 594.00B |
| MRK | Merck & Co. Inc. | $119.37 | +2.58% | 16.5 | 301.17B |
| PFE | Pfizer Inc. | $27.28 | +1.19% | 19.7 | 153.36B |
| BMY | Bristol-Myers Squibb Co | $58.94 | +2.70% | 16.5 | 116.58B |
| ZTS | Zoetis Inc | $116.71 | +0.67% | 21.5 | 57.37B |